CellWell record HH-400191
Incidence of venous thromboembolism in women receiving transdermal oestradiol/testosterone with micronised progesterone in accordance with NICE guidelines
Amy Neville; Dan Reisel; John Benton; Mohit Khera; Louise Newson
2026
In plain language
In a private clinic cohort, 7 of 13,026 peri- and postmenopausal women on transdermal estradiol had venous thromboembolism, an incidence of 0.054% that did not appear higher than expected for their age.
- Evidence
- Emerging
- Design
- Primary research (design unspecified)
Cite this record: https://thecellwell.org/studies/HH-400191
Produced by the CellWell Research Engine, custom software owned and operated by CellWell. All rights reserved. This analysis, its indexing and its evidence classifications are proprietary. Any use, republication or onward sharing must credit CellWell Research Engine (thecellwell.org) as the source.
This is an educational research library, not medical advice. Nothing here may be used to diagnose, treat, cure, or prevent any disease. Always consult a qualified professional.